Eylea’s Role in Combatting Retinal Vision Loss
Eylea, or aflibercept, plays a crucial role in managing vision loss from retinal diseases such as wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. By targeting and blocking vascular endothelial growth factor, Eylea impedes harmful blood vessel formation. The treatment’s unique mechanism and proven efficacy present significant advantages over other therapies. Understanding […]